nivolumabPembrolizumabdocetaxeletaxelAtezolizumabInstituto Nacional de CancerologíaNew England Journal of Medicine
…k M, Paz-Ares L, Creelan B, Horn L, Steins M, et al. First-line nivolumab in stage IV or recurrent non-small-cell lung cancer. New Englan…